Experimental Evaluation of Ethanolic Extract of Carapa guianensis L. Leaf for Its Wound Healing Activity Using Three Wound Models.

Department of Preclinical Sciences, The University of West Indies, Faculty of Medical Sciences, Biochemistry Unit, EWMSC, Trinidad and Tobago.
Evidence-based Complementary and Alternative Medicine (Impact Factor: 1.72). 10/2009; 2011:419612. DOI: 10.1093/ecam/nep160
Source: PubMed

ABSTRACT The leaves of Carapa guianensis have been used to treat ulcers, skin parasites, and skin problems. The ethanolic extract of C. guianensis leaf was evaluated for its antibacterial and wound healing activity using excision, incision and dead space wound models in rats. The animals were randomly divided into two groups (n = 6) in all the models. In the excision wound model test group animals were treated topically with the leaf extract (250 mg kg(-1) body weight) whereas, control animals were treated with petroleum jelly. In the incision and dead space wound models, the test group animals were treated with extract (250 mg kg(-1) day(-1)) orally by mixing in drinking water and the control group animals were maintained with plain drinking water. Healing was assessed by the rate of wound contraction, period of epithelialization, skin breaking strength, granulation tissue weight and hydoxyproline content. On Day 15 extract-treated animals exhibited 100% reduction in the wound area when compared to controls (95%) with significant decrease in the epithelialization period. The extract failed to demonstrate antibacterial activity. Skin breaking strength (P < .001), wet (P < .002) and dry (P < .02) granulation tissue and hydroxyproline content (P < .03) were significantly higher in extract treated animals. The increased rate of wound contraction, skin breaking strength and hydroxyproline content supports potential application of C. guianensis in wound healing.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Today, one of the trends of the pharmaceutical, cosmetic and food market is the development of products with components of natural origin, rationally exploiting biodiversity. Brazilian population makes secular use of medicinal plants including andiroba, whose oil is used in folk medicine as febrifuge, pain-relieving, anti-parasitic, anti-allergic as well as insect repellant. The present study attempts to evaluate the profile of utilization of andiroba by analyzing the patenting trends based on information collected on the databases of the World Intellectual Property Organization, European Patent Office and Brazilian National Institute of Industrial Property in the period from 1990 to 2011. The following parameters were analyzed: chronological aspect of the applications, countries of priority, international patent classification, technologies and actors in the technological platform. The temporal analysis of the applications shows an evident increase despite a discontinuous evolution of the number of applications. Pharmaceutical, chemical and cosmetic areas were identified as the main areas for commercial application of the plant. Brazil is the country with the largest number of applications even though the majority of the patent technologies are already in public domain, indicating that the technological information contained in these documents could be used for research and investment in several areas.
    Revista Brasileira de Farmacognosia 08/2013; 23(4):716-719. · 0.68 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Proline (Pro) plays a versatile role in cell metabolism and physiology. Pro and hydroxypro are major imino acids present in collagen, an important connective tissue protein, essential for wound healing, which is a primary response to tissue injury. This study explains the role of L-pro on cutaneous wound healing in rats when administered both topically and orally. Open excision wounds were made on the back of rats, and 200 μl (200 mg) of pro was administered topically and orally once daily to the experimental rats until the wounds healed completely. The control wounds were left untreated. Granulation tissues formed were removed after day 4 and 8 of post excision wounding, and biochemical parameters such as total protein, collagen, hexosamine, and uronic acid were estimated. Levels of enzymatic and non-enzymatic antioxidants such as catalase, superoxide dismutase, glutathione peroxidase, ascorbic acid, and reduced glutathione were evaluated along with lipid peroxides in the granulation tissues. Tensile strength and period of epithelialization were also measured. It was observed that the treated wounds healed very fast as evidenced by augmented rates of epithelialization and wound contraction, which was also confirmed by histological examinations. The results strappingly authenticate the beneficial effects of the topical administration of L-proline in the acceleration of wound healing than the oral administration and control.
    Amino Acids 03/2013; · 3.91 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The potent biomedical properties of Streptomyces secondary metabolites make them a possible source of promising new targets to use as wound-healing-promoting agents. To investigate the properties of a Streptomyces sp. secondary metabolite, the SEM-1-111 fraction, in the healing full-thickness cutaneous wounds. In this experiment, creams were prepared using a Eucerin ointment base with 5%, 10% or 15% SEM-1-111 added. Circular excision wounds were surgically created on the back of Wistar rats, and the creams were applied daily to the wound area. The negative control group was treated with the vehicle, and the positive control group with a commercial phenytoin 1% cream. We analysed planimetric and histological parameters, and the expression of procollagen-I mRNA. SEM-1-111 substantially influenced wound healing. The cream containing the highest dose of metabolite (15%) significantly decreased wound size during the study, and histological evaluation showed beneficial effects of this concentration in the wound-healing process. Procollagen-I mRNA levels were significantly increased in both the 15% SEM-1-111 group and the phenytoin group compared with the vehicle control on postoperative day 7. Regular topical application of the Streptomyces sp. secondary metabolite SEM-1-111 fraction at a concentration of 15% accelerates the wound-healing process.
    Clinical and Experimental Dermatology 03/2013; 38(2):178-84. · 1.33 Impact Factor

Full-text (4 Sources)

Available from
May 22, 2014